Physician profile
David A Schulsinger
NPI 1285661488
$25,203.97
in general payments reported to CMS, 2019-2025
37 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2020: $579 · 2021: $10K · 2022: $1,194 · 2023: $5,194 · 2024: $5,201 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,005 · Food and Beverage: $3,207 · Honoraria: $1,450 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,004.88 |
| Food and Beverage | $3,207.28 |
| Honoraria | $1,450.00 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $9,567.42 | 2021-2024 | Oxlumo |
| Ambu A/S | $4,587.38 | 2023-2024 | |
| Novo Nordisk INC | $3,867.50 | 2023-2024 | Rivfloza |
| Boston Scientific Corporation | $1,734.41 | 2019-2025 | General - Kidney Stone Disease, Xpeeda Dsl Fiber, Lithoclast |
| Astellas Pharma US INC | $940.63 | 2019-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $726.61 | 2019-2025 | Erleada |
| Coloplast Corp | $697.39 | 2019-2024 | Speedicath |
| Urogen Pharma, INC. | $583.13 | 2022-2025 | Jelmyto |
| Neotract INC. | $332.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $285.62 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $219.85 | 2021-2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $214.39 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $197.89 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Photocure INC | $138.14 | 2019-2024 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $136.37 | 2019-2025 | Bard Urinary Drainage Bag |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $119.31 | 2019-2025 | Resonance |
| Sumitomo Pharma America, INC. | $106.03 | 2023-2024 | Gemtesa |
| Teleflex LLC | $86.66 | 2021-2022 | |
| Myovant Sciences INC. | $71.86 | 2021-2022 | |
| Telix Pharmaceuticals | $70.82 | 2025 | Illuccix |
| Siemens Medical Solutions USA, INC. | $61.60 | 2021 | |
| Rochester Medical Corporation | $60.41 | 2019-2020 | |
| Blue Earth Diagnostics | $56.61 | 2023-2025 | Posluma |
| Dentsply Ih INC. | $49.28 | 2019-2022 | |
| Olympus America INC. | $35.20 | 2025 | Itind System |
| Genzyme Corporation | $31.15 | 2020 | |
| Dendreon Pharmaceuticals LLC | $29.69 | 2025 | Provenge |
| Immunitybio, INC. | $29.10 | 2025 | |
| Pfizer INC. | $26.65 | 2019 | |
| Agiliti Surgical, INC. | $24.67 | 2023 | Sonablate |
| Dentsply Ih Ab | $23.96 | 2025 | Lofric |
| Civco Medical Instruments | $21.39 | 2025 | |
| Endo USA, INC. | $16.68 | 2025 | Xiaflex, Aveed |
| Hollister Incorporated | $15.35 | 2023 | Infyna Chic, Vapro Plus Pocket, Vapro |
| Tolmar Pharmaceuticals, INC. | $15.04 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Travere Therapeutics, INC. | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schulsinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.